Diabetes mellitus affects more than 10% of people with HIV, and its incidence is rising as the population ages, according to the National Institutes of Health. Antiretroviral therapies that treat HIV ...

New NIH-Funded @HopkinsMedicine Study Finds Switching to Integrase Inhibitors from Protease Inhibitors Is Associated with New #Diabetes Risk in People with #HIV › Diabetes mellitus affects more than ...

Please provide your email address to receive an email when new articles are posted on . Previous studies have shown that DOR/ISL was noninferior to continuing current HIV therapies At 48 weeks, 91.8% ...

The table below is a review of notable updates that occurred in February 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

At the 2026 Conference on Retroviruses and Opportunistic Infections, Gilead and Merck demonstrated that their respective daily oral HIV drugs can match current therapies in keeping the virus at bay.

A new once-daily HIV pill combining doravirine and islatravir shows strong safety and effectiveness, offering a promising alternative to existing therapies Researchers at Queen Mary University of ...

Background With the ageing of people living with HIV/AIDS (PLWHA), the prevalence of chronic comorbidities, especially hyperglycaemia, is increasing among elderly PLWHA. Antiretroviral therapy (ART) ...

The table below is a review of notable updates that occurred in November 2025 for investigational products in development (not an inclusive list). Click on the status ...

A Q&A With Rajesh Gandhi, MD. GANDHI: The main reasons patients and their clinicians consider switching are to simplify treatment, reduce drug interactions, and mitigate long-term safety risks. In my ...

When people think about automation, the focus is almost always on what it takes away. They see it as machines taking over tasks, making jobs disappear. But there’s another side to the story that’s ...

Three chemical structures with various rods and rings in multiple colors appear over a gray, bumpy background. An X-ray crystal structure of MK-8527 triphosphate (TP) bound to the complex of HIV ...